ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,108,000 | -9.1% | 330,200 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $4,520,000 | +73.3% | 330,200 | -6.4% | 0.01% | +75.0% |
| Q2 2016 | $2,608,000 | +12.2% | 352,900 | -3.0% | 0.00% | 0.0% |
| Q1 2016 | $2,325,000 | -3.6% | 363,900 | -5.7% | 0.00% | 0.0% |
| Q4 2015 | $2,411,000 | +7.0% | 385,800 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $2,253,000 | -29.4% | 385,800 | 0.0% | 0.00% | -20.0% |
| Q2 2015 | $3,191,000 | +28.0% | 385,800 | 0.0% | 0.01% | +66.7% |
| Q1 2015 | $2,492,000 | 0.0% | 385,800 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,492,000 | +19.6% | 385,800 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $2,083,000 | -15.3% | 385,800 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $2,458,000 | -12.7% | 385,800 | 0.0% | 0.00% | -25.0% |
| Q1 2014 | $2,816,000 | +4.3% | 385,800 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $2,701,000 | -62.7% | 385,800 | -2.1% | 0.00% | -69.2% |
| Q3 2013 | $7,251,000 | +6.3% | 394,056 | +1.1% | 0.01% | -7.1% |
| Q2 2013 | $6,820,000 | – | 389,941 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
| Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
| Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
| Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
| Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
| Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
| Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
| PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
| HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |